Black Diamond Therapeutic: Q4 Earnings Insights

Black Diamond Therapeutic BDTX reported its Q4 earnings results on Tuesday, March 12, 2024 at 08:00 AM.

Here's what investors need to know about the announcement.

Earnings

Black Diamond Therapeutic beat estimated earnings by 28.000000000000004%, reporting an EPS of $-0.34 versus an estimate of $-0.47.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.01 which was followed by a 5.0% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Black Diamond Therapeutic visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

BDTX Logo
BDTXBlack Diamond Therapeutics Inc
$2.31-4.94%

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings
Edge Rankings
Momentum
13.34
Growth
Not Available
Quality
Not Available
Value
71.96
Price Trend
Short
Medium
Long
Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise

Comments
Loading...